The Potential of Candesartan to Retard the Progression of Aortic Stenosis (ROCK-AS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00699452|
Recruitment Status : Unknown
Verified May 2009 by Helsinki University.
Recruitment status was: Recruiting
First Posted : June 18, 2008
Last Update Posted : May 19, 2009
Information provided by:
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||December 2014|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Helske-Suihko S, Laine M, Lommi J, Kaartinen M, Werkkala K, Kovanen PT, Kupari M. Is blockade of the Renin-Angiotensin system able to reverse the structural and functional remodeling of the left ventricle in severe aortic stenosis? J Cardiovasc Pharmacol. 2015 Mar;65(3):233-40. doi: 10.1097/FJC.0000000000000182.